Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis

Budihardjo, 1999, Biochemical pathways of caspase activation during apoptosis, Annu. Rev. Cell. Dev. Biol., 15, 269, 10.1146/annurev.cellbio.15.1.269 Chervonsky, 1999, Apoptotic and effector pathways in autoimmunity, Cur. Opin. Immunol., 11, 684, 10.1016/S0952-7915(99)00037-0 Ciusani, 1998, Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients, J. Neuroimmunol., 82, 5, 10.1016/S0165-5728(97)00177-X Comi, 2000, Defective T cell Fas function in patients with multiple sclerosis, Neurology, 55, 921, 10.1212/WNL.55.7.921 Correale, 2000, Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS, J. Neuroimmunol., 109, 197, 10.1016/S0165-5728(00)00326-X Cui, 2000, Lipopolysaccharide induces the expression of cellular inhibitor of apoptosis protein-2 in human macrophages, Biochim. Biophys. Acta, 1524, 178, 10.1016/S0304-4165(00)00155-0 Deveraux, 1999, IAP family proteins: suppressors of apoptosis, Gene Dev., 13, 239, 10.1101/gad.13.3.239 Deveraux, 1998, IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases, EMBO J., 17, 2215, 10.1093/emboj/17.8.2215 Deveraux, 1999, Endogenous inhibitors of caspases, J. Clin. Immunol., 19, 388, 10.1023/A:1020502800208 Inoue, 1997, Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy, J. Neuroimmunol., 75, 141, 10.1016/S0165-5728(97)00012-X Kobayashi, 1999, Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation, Proc. Natl. Acad. Sci. U. S. A., 96, 1457, 10.1073/pnas.96.4.1457 Krammer, 2000, CD95's deadly mission in the immune system, Nature, 407, 789, 10.1038/35037728 Lin, 2000, KIAP, a novel member of the inhibitor of apoptosis protein family, Biochem. Biophys. Res. Commun., 279, 820, 10.1006/bbrc.2000.4027 Macchi, 1999, Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis, NeuroReport, 10, 399, 10.1097/00001756-199902050-00034 Magaud, 1989, Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine, J. Histochem. Cytochem., 37, 1517, 10.1177/37.10.2476478 Miller, 1999, An exegesis of IAPs: salvation and surprises from BIR motifs, Trends Cell Biol., 9, 323, 10.1016/S0962-8924(99)01609-8 Newton, 1998, The Bcl-2 family and cell death regulation, Curr. Opin. Gene Dev., 8, 68, 10.1016/S0959-437X(98)80064-6 Pender, 1999, Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance, Immunol. Cell Biol., 77, 216, 10.1046/j.1440-1711.1999.00818.x Roy, 1997, The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases, EMBO J., 16, 6914, 10.1093/emboj/16.23.6914 Sakai, 1999, Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy, J. Interferon Cytokine Res., 19, 999, 10.1089/107999099313208 Scaffidi, 1999, Apoptosis signaling in lymphocytes, Curr. Opin. Immunol., 11, 277, 10.1016/S0952-7915(99)80045-4 Schmidt, 2000, T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy, Brain, 123, 1431, 10.1093/brain/123.7.1431 Segal, 2000, Fas(t) track to apoptosis in MS-TNF receptors may suppress or potentiate CNS demyelination, Neurology, 55, 906, 10.1212/WNL.55.7.906 Semra, 2001, Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis, J. Neuroimmunol., 113, 268, 10.1016/S0165-5728(00)00443-4 Sharief, 2000, Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis, J. Neuroimmunol., 109, 236, 10.1016/S0165-5728(00)00325-8 Sharief, 2000, Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis, J. Neuroimmunol., 111, 203, 10.1016/S0165-5728(00)00310-6 Tran, 1999, Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells, Biochem. Biophys. Res. Commun., 264, 781, 10.1006/bbrc.1999.1589 Tschopp, 1998, Inhibition of Fas death signals by FLIPs, Curr. Opin. Immunol., 10, 552, 10.1016/S0952-7915(98)80223-9 Van Parijs, 1998, Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes, J. Immunol., 160, 2065, 10.4049/jimmunol.160.5.2065 Vucic, 2000, ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas, Curr. Biol., 10, 1359, 10.1016/S0960-9822(00)00781-8 Wang, 1998, NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation, Science, 281, 1680, 10.1126/science.281.5383.1680 Yang, 2000, The IAP family: endogenous caspase inhibitors with multiple biological activities, Cell Res., 10, 169, 10.1038/sj.cr.7290046 Yang, 2000, Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli, Science, 288, 874, 10.1126/science.288.5467.874 Zang, 1999, Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis, Eur. J. Immunol., 29, 1692, 10.1002/(SICI)1521-4141(199905)29:05<1692::AID-IMMU1692>3.0.CO;2-H Zettl, 1998, Bcl-2 expressing T lymphocytes in multiple sclerosis lesions, Neuropathol. Appl. Neurobiol., 24, 202, 10.1046/j.1365-2990.1998.00110.x Zipp, 1998, Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis, J. Neuroimmunol., 86, 151, 10.1016/S0165-5728(98)00032-0 Zipp, 1999, Immune (dys)regulation in multiple sclerosis: role of the CD95–CD95 ligand system, Immunol. Today, 20, 550, 10.1016/S0167-5699(99)01545-5